Literature DB >> 7499865

Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1.

M E Fuentes1, S K Durham, M R Swerdel, A C Lewin, D S Barton, J R Megill, R Bravo, S A Lira.   

Abstract

Transgenic mice overexpressing the chemokine monocyte chemoattractant protein-1 (MCP-1) in the thymus and central nervous system have a higher number of mononuclear cells in those tissues than do control littermates. In the thymus, there is a modest increase in the number of Mac-1 and F4/80 positive cells, but no apparent change in the number of lymphoid cells. A more pronounced mononuclear infiltrate is detected in transgenic mice expressing MCP-1 in the brain. The vast majority of the recruited cells in the brain are monocytes and macrophages, as defined by light microscopy, and ultrastructural and immunohistochemical criteria. Such cells are found in a perivascular orientation with minimal parenchymal infiltration, possibly as a consequence of the accumulation of MCP-1 in the vessels, as shown by immunohistochemistry. The mononuclear cell infiltrate in the brain can be significantly amplified by LPS treatment, suggesting that the recruitment properties of MCP-1 can be potentiated by additional factors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499865

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  121 in total

Review 1.  Gene targeting of chemokines and their receptors.

Authors:  D M Slattery; N Gerard; C Gerard
Journal:  Springer Semin Immunopathol       Date:  2000

2.  Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1.

Authors:  B Johnston; A R Burns; M Suematsu; T B Issekutz; R C Woodman; P Kubes
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

3.  Blood-brain barrier pathophysiology in traumatic brain injury.

Authors:  Adam Chodobski; Brian J Zink; Joanna Szmydynger-Chodobska
Journal:  Transl Stroke Res       Date:  2011-12       Impact factor: 6.829

Review 4.  Migration and fate of therapeutic stem cells in different brain disease models.

Authors:  B J Carney; K Shah
Journal:  Neuroscience       Date:  2011-09-14       Impact factor: 3.590

5.  Expression of astrocytic type 2 angiotensin receptor in central nervous system inflammation correlates with blood-brain barrier breakdown.

Authors:  Laila Füchtbauer; Henrik Toft-Hansen; Reza Khorooshi; Trevor Owens
Journal:  J Mol Neurosci       Date:  2010-04-23       Impact factor: 3.444

6.  Adeno associated viral-mediated intraosseous labeling of bone marrow derived cells for CNS tracking.

Authors:  Maj-Linda B Selenica; Patrick Reid; Gabriela Pena; Jennifer Alvarez; Jerry B Hunt; Kevin R Nash; Dave Morgan; Marcia N Gordon; Daniel C Lee
Journal:  J Immunol Methods       Date:  2016-01-16       Impact factor: 2.303

Review 7.  Role of chemokines, innate and adaptive immunity.

Authors:  Kurt A Zimmerman; Katharina Hopp; Michal Mrug
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

8.  LPS-induced murine systemic inflammation is driven by parenchymal cell activation and exclusively predicted by early MCP-1 plasma levels.

Authors:  Justin E Juskewitch; Bruce E Knudsen; Jeffrey L Platt; Karl A Nath; Keith L Knutson; Gregory J Brunn; Joseph P Grande
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

9.  HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS.

Authors:  Eliseo A Eugenin; Gawain Dyer; Tina M Calderon; Joan W Berman
Journal:  Glia       Date:  2005-03       Impact factor: 7.452

Review 10.  Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.

Authors:  Bridgette D Semple; Thomas Kossmann; Maria Cristina Morganti-Kossmann
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.